specialists from whom assistance may be obtained in difficult or controversial cases.
The results of treatment of many types of malignant bone tumour leave no ground for complacency at the present time and with the development of new antimitotic drugs, regional perfusion techniques and more effective radiotherapy it is particularly important to have a means of assessing and comparing these different therapies; this the Registry will provide. The development of malignant bone tumours is one of the potential consequences of increased radioactive contamination of the atmosphere. Although the levels of radioactivity prevailing at the present time are unlikely to be important in this respect, it will be of extreme value to have accurate statistics by which this risk may be measured.
The success of this venture will rest on the enthusiasm of its secretary and on the cooperation of all doctors in Scotland who come across cases of bone tumour. The Orthopaedic Department of the Western Infirmary, Glasgow, has generously made available its entire collection of bone tumours as a starting point for the Registry. Dr Mary Catto, lecturer in orthopaedic pathology at Glasgow University is acting as registrar with the assistance of a full-time secretary, and all correspondence should be addressed to her at the Pathology Department, Western Infirmary, Glasgow, W.1. It is to be hoped that the Registry will provide an opportunity for clinicians, radiologists and pathologists to integrate their knowledge to the benefit of the patient. 
